SCHEMBL4139802

SCHEMBL4139802

O=C(O)c1ccc2cc3n(c2c1)CC=Nc1ccccc1-3

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FGFR1 P11362 2/20 0.38
CA12 O43570 2/20 0.37
CA9 Q16790 2/20 0.37
CA1 P00915 1/20 0.37
CA2 P00918 1/20 0.37
SCN2A Q99250 1/20 0.37
HSD17B10 Q99714 1/20 0.36
SRD5A2 P31213 2/20 0.36
POLB P06746 2/20 0.36
KMT2A Q03164 2/20 0.36
SRD5A1 P18405 1/20 0.36
RPS6KA3 P51812 3/20 0.36
RPS6KA2 Q15349 2/20 0.36
ACLY P53396 2/20 0.35
TTR P02766 1/20 0.35
PTPRC P08575 2/20 0.35
RXFP1 Q9HBX9 2/20 0.34
MEN1 O00255 1/20 0.34
PKM P14618 1/20 0.34
HTT P42858 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL270972 0.77 POLB (0.40) FGFR1CA12CA9CA1CA2
SCHEMBL4823794 0.73 SMN1; SMN2 (0.37) FGFR1POLBKMT2ARPS6KA3RPS6KA2
SCHEMBL3574670 0.72 SRD5A2 (0.50) SRD5A2SRD5A1RPS6KA3RPS6KA2ALDH1A1
SCHEMBL50870 0.71 POLB (0.39) FGFR1CA12CA9CA1CA2
SCHEMBL4144644 0.71 RPS6KA2 (0.47) RPS6KA3RPS6KA2
SCHEMBL3080179 0.70 RPS6KA2 (0.54) RPS6KA3RPS6KA2
SCHEMBL3092044 0.69 RPS6KA2 (0.43) SRD5A2SRD5A1RPS6KA3RPS6KA2
SCHEMBL3095903 0.69 RPS6KA2 (0.43) RPS6KA3RPS6KA2RAB9A
SCHEMBL51501 0.69 RPS6KA2 (0.37) FGFR1HSD17B10SRD5A2POLBKMT2A
SCHEMBL3073902 0.68 RPS6KA2 (0.41) CA12CA9SRD5A2POLBKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090136449-A1 Tetracyclic Indole Derivatives as Antiviral Agents ISTITUTO DI RICERCHE DI BIOLOGIA MOLECOLARE P. ANGELETTI SPA (IT) 2009-05-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090136449-A1 Tetracyclic Indole Derivatives as Antiviral Agents IDO1, IDO2, ZC3HAV1 FGFR1 3791/4885CA12 3334/4885CA9 3122/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.